According to a company statement, Glenmark Pharmaceuticals Inc., USA, an arm of the company, has launched the Epinephrine injection of strength 10 mg/10 mL (1 mg/mL) multiple-dose vial.
The Mumbai-based company had received approval from Drug Controller General of India (DCGI) last month to conduct clinical trials of Favipiravir antiviral tablets for the treatment of COVID-19 patients.
The approved product is a generic version of MSD International's Vytorin tablets.
